ARCHIVES

FDA seeks support for reorganization of cancer programs, but debate continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002